CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 81 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-22 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +345,470 | 345,470 | ||
| 2023-02-22 | Bilbo Patrick Chief Operating Officer | Grant or award | +327,386 | 505,013 | ||
| 2023-02-22 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +388,654 | 388,654 | ||
| 2023-02-22 | Francisco David Chief Financial Officer | Grant or award | +242,508 | 291,929 | ||
| 2023-02-22 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +287,892 | 287,892 | ||
| 2023-02-22 | Gillheeney Gary S. President and CEO | Grant or award | +896,414 | 1,774,402 | ||
| 2023-02-22 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +1,655,381 | 1,655,381 | ||
| 2023-02-22 | Duraibabu Prathyusha Director | Grant or award | +65,737 | 97,624 | ||
| 2023-02-22 | Quintero Gilberto Director | Grant or award | +65,737 | 89,650 | ||
| 2023-02-22 | Korfin Michele Ilene Director | Grant or award | +65,737 | 89,650 | ||
| 2023-02-22 | Driscoll Michael Joseph Director | Grant or award | +65,737 | 91,284 | ||
| 2023-02-22 | Giacomin Jon L Director | Grant or award | +65,737 | 91,603 | ||
| 2023-02-22 | Leibowitz Arthur S Director | Grant or award | +65,737 | 136,591 | ||
| 2023-02-16 | Montecalvo Antonio S. VP Health Policy & Contracting | Shares withheld for taxes | −717 | $2.75 | $2K | 39,585 |
| 2023-02-16 | Freedman Lori VP and General Counsel | Shares withheld for taxes | −765 | $2.75 | $2K | 67,445 |
| 2023-02-16 | Grow Brian Chief Commercial Officer | Shares withheld for taxes | −799 | $2.75 | $2K | 83,599 |
| 2023-02-16 | Bilbo Patrick Chief Operating Officer | Shares withheld for taxes | −936 | $2.75 | $3K | 177,627 |
| 2023-02-16 | Francisco David Chief Financial Officer | Shares withheld for taxes | −953 | $2.75 | $3K | 49,421 |
| 2023-02-16 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −3,787 | $2.75 | $10K | 877,988 |
| 2023-02-15 | Montecalvo Antonio S. VP Health Policy & Contracting | Shares withheld for taxes | −1,249 | $2.92 | $4K | 40,302 |
Page 13 of 24 · 473 trades